Smt.Kanuri Santhamma Retina Vitreous Centre, L V Prasad Eye Institute, Hyderabad, India.
Department of Glaucoma, Suraj Eye Institute, Nagpur, India.
Indian J Ophthalmol. 2018 Jul;66(7):916-920. doi: 10.4103/ijo.IJO_910_17.
Diabetic retinopathy (DR) and glaucoma are emerging causes of blindness and visual impairment in India and the world. Both diseases do not have any early warning symptoms, and once the symptoms appear, the diseases are reasonably advanced. Because of the long-standing nature of the diseases, one cannot adopt the cataract detection and treatment model so successfully developed in India. It requires an altogether different approach for screening and related infrastructure including human capital development. The solutions developed to reduce the burden of DR/glaucoma should be customized to urban, semi-urban, and rural areas. Greater advocacy, improving the health-seeking behavior, development of infrastructure and skilled personnel appropriate for the points of care, and an emphasis in comprehensive eye care are some of the solutions.
糖尿病视网膜病变(DR)和青光眼是印度乃至全球致盲和视力损害的主要原因。这两种疾病均无早期预警症状,且一旦出现症状,病情通常已较为严重。由于这些疾病的长期性,印度在白内障检测和治疗方面取得的成功经验无法直接应用于这两种疾病。因此,针对这两种疾病,筛查和相关基础设施(包括人力资本开发)需要采取不同的方法。针对 DR/青光眼的缓解方案需要根据城市、半城市和农村地区的具体情况进行定制。加强宣传、改善寻医行为、基础设施建设和培养适合基层医疗点的专业人员,以及重视全面的眼保健,都是可行的解决方案。